Download your free iOS app to support optimized use and aids in the result interpretation of the VIDAS Emergency & Critical Care assays.
Save time when every minute counts: all the information you need for confident clinical decision- making with the VIDAS® Emergency & Critical Care assays.
Designed for healthcare professionals, MYACUTECASE™ is a first-of-its-kind app. Used in conjunction with clinical assessment and other laboratory findings, it provides comprehensive biomarker information and useful tools for:
Rapid diagnosis: rule-out or rule-in of heart failure and acute myocardial infarction
Early detection of sepsis, monitoring of patient response to therapy, and safe discontinuation of antibiotics
Safe exclusion of suspected pulmonary embolism / deep vein thrombosis in patients with low/intermediate or unlikely pre-test probability
Based on your choice of pre-test probability scoring and/or validated clinical decision trees, MYACUTECASE™ aids in the result interpretation of the VIDAS® Emergency & Critical Care assays, automatically suggests and reminds you of the next steps in the diagnostic process and provides recommendations for treatment.
MYACUTECASE™ is an IVD product, based on international literature, guidelines and expert recommendations. It’s compliant with the intended use of the VIDAS® Emergency & Critical Care assays (VIDAS® B·R·A·H·M·S PCT™, VIDAS® D-Dimer Exclusion™ II, VIDAS® NT-proBNP2, VIDAS® High sensitive Troponin I).
Features
- Manage your case
- Obtain assay information
- Aid in result interpretation of VIDAS® assays using validated decision trees and test-specific cut-offs
- Patient management recommendations based on validated instructions for use for assays
- Pre-test probability scoring
- Choice of different scoring systems
- On-demand storage of patient case
- Notifications for follow-up testing / serial measurements
- Monitoring of PCT results for guided antibiotic therapy
- Clinical utility
- International guidelines for use
- Expert recommendations
Testimonial
Experts feedbacks on their usage of MYACUTECASE™ app
Pr. Yann-Erick Claessens
Professor of Emergency Medicine, Monaco
Dr. Eden A. Ferrer-Lasala
Emergency Medicine Physician Asian Hospital and Medical center
Education Videos
The Value of Emergency Biomarkers
How do emergency physicians secure their decisions when they only have 7 minutes per patient?
In this first video, Professor Yann-Erick Claessens, Head of the Emergency Department at Princess Grace Hospital in Monaco, explains how D-dimer, procalcitonin (PCT), NT-proBNP and high-sensitivity cardiac troponin I are used to safely rule in or rule out a diagnostic hypothesis, support efficient triage and optimize patient care.
Procalcitonin (PCT) in the diagnosis and management of lower respiratory tract infection (LRTI)
Discover with Professor Yann-Erick Claessens, Head of the Emergency Department at Princess Grace Hospital in Monaco:
- How PCT informs clinicians on the likelihood of bacterial infection
- How PCT can be used to guide decisions on antibiotic therapy in order to decrease antibiotic consumption, improve patient outcomes and reduce hospital costs
- How using PCT to guide treatment decisions helps decrease the use of antibiotics and improve patient outcomes while reducing hospital costs
When pulmonary embolism (PE) is suspected, how does D-dimer help?
In this video, Professor Yann-Erick Claessens, Head of the Emergency Department at Princess Grace Hospital in Monaco, highlights the particular clinical value of D-Dimer as a safe and cost-effective exclusion test in patients with a low/intermediate or unlikely pre-test probability for PE.
High-sensitive cardiac Troponin I in acute myocardial infarction (AMI)
Professor Yann-Erick Claessens explains how High-sensitive cardiac Troponin I helps classify 70% of suspected acute myocardial infarction patients within 2 hours, decrease cardiac stress testing, discharge patients earlier from the ED and reduce global hospital costs.
How to use NT-proBNP to improve the diagnosis of acute heart failure
Professor Yann-Erick Claessens, Head of the Emergency Department at Princess Grace Hospital in Monaco, highlights the value of NT-proBNP in early identification of acute heart failure to improve patient outcomes and save hospital resources.
NT-proBNP in heart failure management
Are you an Emergency Physician?
Prof. Meune shows how NT-proBNP can be used in combination with echocardiography for diagnostic and prognostic purposes and to guide therapy. He also highlights the differences between NT-proBNP and BNP.
NT-proBNP in heart failure management
Are you a General Practitioner?
Prof. Meune shows how NT-proBNP can be used in combination with echocardiography for diagnostic and prognostic purposes and to guide therapy. He also highlights the differences between NT-proBNP and BNP.
NT-proBNP in heart failure management
Are you a Cardiologist?
Prof. Meune shows how NT-proBNP can be used in combination with echocardiography for diagnostic and prognostic purposes and to guide therapy. He also highlights the differences between NT-proBNP and BNP.
NT-proBNP in heart failure management
Are you a Biologist?
Prof. Meune shows how NT-proBNP can be used in combination with echocardiography for diagnostic and prognostic purposes and to guide therapy. He also highlights the differences between NT-proBNP and BNP.
Clinical Booklets
The information in these booklets is for educational purposes only and is not intended to be exhaustive. It is not intended to be a substitute for professional medical advice. Always consult a medical director, physician, or other qualified health provider regarding processes and/or protocols for diagnosis and treatment of a medical condition. bioMérieux assumes no responsibility or liability for any diagnosis established or treatment prescribed by the physician.
